Fatality after a single dermal application of lindane lotion

Archives of Environmental and Occupational Health

Volumn 62, Issue 4, 2007, Pages 201-203

  Sudakin, Daniel L ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Drug safety; EPA; FDA; Lice; Lindane; Pharmaceutical; Risk assessment; Scabies; Toxicology

Indexed keywords

CARBON DIOXIDE; LINDANE; OXYGEN;

ADULT; ARTICLE; AUTOPSY; BLOOD CULTURE; BLOOD PRESSURE MONITORING; BODY WEIGHT; BRAIN ISCHEMIA; CARBON DIOXIDE BLOOD LEVEL; CASE REPORT; CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG ABSORPTION; DRUG SAFETY; ELECTROENCEPHALOGRAM; FATALITY; FOOD AND DRUG ADMINISTRATION; HEMODYNAMIC MONITORING; HOSPITAL PATIENT; HUMAN; HYPOTENSION; HYPOXEMIA; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; LINDANE LOTION; LOTION; LUMBAR PUNCTURE; MALE; MENINGITIS; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; OXYGEN SATURATION; PEDICULOSIS; PH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESPIRATORY ACIDOSIS; RISK ASSESSMENT; SCABIES; SCRATCHING; SEIZURE; SEPSIS; SKIN ABSORPTION; STOMACH CANCER; TOXICITY; TOXICOLOGY; URINARY TRACT INFECTION;

PHTHIRAPTERA;

EID: 43249087879     PISSN: 19338244     EISSN: 21544700     Source Type: Journal    
DOI: 10.3200/AEOH.62.4.201-203     Document Type: Article

References (17)

1. US Environmental Protection Agency, Office of Pesticide Programs. Recognition and Management of Pesticide Poisonings. 5th ed. Washington, DC:US EPA; 1999.
2. Sunol C, Tusell JM, Gelpi E, Rodriguez-Farre E GABAergic modulation of lindane (gamma-hexachlorocyclohexane)-induced seizures. Toxicol Appl Pharmacol. 1989;100:1-8.
3. US Environmental Protection Agency. Addendum to the 2002 Lindane Reregistration Eligibility Decision (RED). Washington, DC:US EPA; 2006. EPA 738-R-06-028.
4. US Environmental Protection Agency. Lindane; Cancellation Order. Federal Register, 74905-74907. February 13, 2006.
5. Franz TJ, Lehman PA, Franz SF, Guin JD Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol. 1996;132:901-905.
6. Ginsburg CM, Lowry W, Reisch JS Absorption of lindane (gamma benzene hexachloride) in infants and children. J Pediatr. 1977;91:998-1000.
7. Lee B, Groth P Scabies:transcutaneous poisoning during treatment. Pediatrics. 1977;59:643.
8. Lee B, Groth P, Turner W Suspected reactions to gamma benzene hexachloride. J Am Med Assoc. 1976;236:2846.
9. Solomon BA, Haut SR, Carr EM, Shalita AR Neurotoxic reaction to lindane in an HIV-seropositive patient. An old medication's new problem. J Fam Pract. 1995;40:291-296.
10. Tenenbein M Seizures after lindane therapy. J Am Geriatr Soc. 1991;39:394-395.
11. US Food and Drug Administration, Center for Drug Evaluation and Research. FDA Public Health Advisory:Safety of Topical Lindane Products for the Treatment of Scabies and Lice. Washington, DC:FDA; 2003. http://www.fda.gov/cder/drug/infopage/lindane/lindanePHA.htm
12. Burkhart CG, Burkhart CN Safety and efficacy of pediculicides for head lice. Expert Opin Drug Saf. 2006;5:169-179.
13. Wendel K, Rompalo A Scabies and pediculosis pubis:an update of treatment regimens and general review. Clin Infect Dis. 2002;35:S146-S151.
14. Orion E, Marcos B, Davidovici B, Wolf R Itch and scratch:scabies and pediculosis. Clin Dermatol. 2006;24:168-175.
15. Erdman AR Pesticides. In:Dart RC, ed. Medical Toxicology. 3rd ed. Philadelphia, PA:Lippincott, Williams & Wilkins; 2004:1475-1496.
16. US Environmental Protection Agency, Office of Prevention, Pesticides, and Toxic Substances. Revised Assessment of Risk from Use of Lindane for Treatment of Lice and Scabies. Washington, DC:US EPA; 2002. http://www.lindane.com/pdf/EPA-Revised_Assessment-2002-07-31.pdf
17. Psaty BM, Burke SP Protecting the Health of the Public-Institute of Medicine Recommendations on Drug Safety. N Engl J Med. 2006;355:1753-1755.